国家药品监督管理局局长郑筱萸近日指出，国家医药管理局将从严实施药品监管，推行药品研究登记备案准入制度，加大药品研究中违法违规行为的处罚力度，采取有效措施，严格控制药品生产企业准入条件。国家鼓励以兼并、入股、联合等方式进行医药企业资产重组。以加速治理低水平 Zheng Wei, director of the State Drug Administration, pointed out in recent days that the State Administration of Pharmacy will strictly implement drug supervision, implement the entry approval system for drug research and registration, increase penalties for violations of laws and regulations in drug research, take effective measures, and strictly control drug production. Enterprise access conditions. The State encourages the reorganization of assets of pharmaceutical companies by way of mergers, shares, or alliances. To accelerate the low level of governance